The Prevalence of Glucose Intolerance in Japanese Schizophrenic Patients With a Normal Fasting Glucose Level

被引:4
作者
Ono, Shin [1 ]
Suzuki, Yutaro [1 ]
Fukui, Naoki [1 ]
Sugai, Takuro [1 ]
Watanabe, Junzo [1 ]
Tsuneyama, Nobuto [1 ]
Saito, Mami [1 ]
Someya, Toshiyuki [1 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata 9518510, Japan
关键词
antipsychotics; glucose tolerance test; glucose metabolism; impaired glucose tolerance; schizophrenia; ANTIPSYCHOTIC-DRUGS; METABOLIC SYNDROME; INSULIN-SECRETION; DIABETES-MELLITUS; AGE; ABNORMALITIES; TOLERANCE; DISORDER;
D O I
10.1097/JCP.0b013e3182905775
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The prevalence of diabetes in patients with schizophrenia is 2- to 3-fold higher than in the general population. Glucose abnormalities were detected in 11.9% of Japanese schizophrenic patients in a recent cross-sectional study that included fasting glucose monitoring. However, detailed studies of glucose intolerance using the glucose tolerance test have been limited in Japanese patients with schizophrenia. We investigated the prevalence of abnormal glucose tolerance after glucose loading among Japanese inpatients with schizophrenia, with normal fasting glucose levels. Method: A total of 258 inpatients with schizophrenia participated in this study after giving their written informed consent. A 75-g oral glucose tolerance test was conducted in the morning after a 12-hour overnight fast. Results: Among patients with normal fasting glucose, 81.3% had normal glucose tolerance, 17.3% had impaired glucose tolerance, and 1.3% were diagnosed with diabetes. Conclusions: This study showed that the frequency of impaired glucose tolerance in patients with schizophrenia with normal fasting glucose levels might be higher than in the general population. Careful monitoring and screening of patients with schizophrenia for abnormal glucose metabolism might therefore be necessary.
引用
收藏
页码:525 / 527
页数:3
相关论文
共 22 条
[1]   Mechanisms of the age-associated deterioration in glucose tolerance - Contribution of alterations in insulin secretion, action, and clearance [J].
Basu, R ;
Breda, E ;
Oberg, AL ;
Powell, CC ;
Dalla Man, C ;
Basu, A ;
Vittone, JL ;
Klee, GG ;
Arora, P ;
Jensen, MD ;
Toffolo, G ;
Cobelli, C ;
Rizza, RA .
DIABETES, 2003, 52 (07) :1738-1748
[2]   Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia [J].
Bushe, C ;
Holt, R .
BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 :S67-S71
[3]   Insulin sensitivity differs among ethnic groups with a compensatory response in β-cell function [J].
Chiu, KC ;
Cohan, P ;
Lee, NP ;
Chuang, LM .
DIABETES CARE, 2000, 23 (09) :1353-1358
[4]   Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders [J].
Cohen, D ;
Stolk, RP ;
Grobbee, DE ;
Gispen-De Wied, CC .
DIABETES CARE, 2006, 29 (04) :786-791
[5]   Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: A preliminary report [J].
Cohn, Tony A. ;
Remington, Gary ;
Zipursky, Robert B. ;
Azad, Azar ;
Connolly, Philip ;
Wolever, Thomas M. S. .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2006, 51 (06) :382-386
[6]  
De Hert M, 2006, Clin Pract Epidemiol Ment Health, V2, P14
[7]  
De Hert M, 2006, DRUG SAFETY, V29, P979
[8]  
Genuth S, 2003, DIABETES CARE, V26, P3160
[9]   Excess mortality of mental disorder [J].
Harris, EC ;
Barraclough, B .
BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 :11-53
[10]   Independent influence of age on basal insulin secretion in nondiabetic humans [J].
Iozzo, P ;
Beck-Nielsen, H ;
Laakso, M ;
Smith, U ;
Yki-Järvinen, H ;
Ferrannini, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03) :863-868